Faculty

Institution

Unit

Venue

Michael A. Rogawski

University of California, Davis

Affiliations

School of Medicine

Neurology

NoneMichael A. Rogawski is currently serving as a Neurology faculty at University of California, Davis.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Michael A. Rogawski

University of California, Davis

You can click a keyword to filter the displayed items

neurology neuroscience pharmacology epilepsy neuropharmacology medicine neurophysiology receptors electrophysiology neurochemistry systems neuroscience signal transduction brain science pharmacotherapy cellular neurobiology neuroanatomy neural science experimental pharmacology antiepileptic drugs pharmacokinetics medicinal research mechanisms of action anticonvulsant activity mammalian biology pharmacological research experimental medicine molecular neurobiology neurotransmission clinical neuroscience drug development ketogenic diet neuroprotection brain stimulation pituitary gland neuroinflammation cultured hippocampal neurons antiseizure drugs cellular physiology protein science neuropsychopharmacology peptides drug targeting brain circuitry neuromodulation (medicine) brain function drug safety clinical neurology basic mechanisms catamenial epilepsy rat model seizure susceptibility status epilepticus neuroactive steroids molecular physiology respiratory medicine child neurology neural mechanisms clinical pharmacology neurotransmitters clinical toxicology ampa receptors lateral geniculate neurons rat basolateral amygdala convection-enhanced delivery n-methyl-d-aspartate receptor psychoneuroendocrinology animal physiology applied pharmacology molecular psychiatry therapeutic efficacy translational pharmacology treatment development psychopharmacology experimental toxicology dopamine novel therapies neuropsychiatry translational psychiatry

Notable Scholarly Works

Notable Federal Grants

Collaborators

Crossover Study Evaluating the Effect of Seizures on the Absorption of Diazepam From a Buccal Film Formulation in Children With Epilepsy (P9-1.006). Neurology (2024)

Gary SlatkoStephen WargackiMichael Rogawski

buccal film formulationpharmacologyneurologychild neurologyabsorptioncrossover studyepilepsy

Efficacy of Ep102 (Oral Fospropofol) for the Acute Treatment of Migraine in an Open-Label Proof-Of-Concept Trial: Effect of Time to Treatment (P6-12.009). Neurology (2024)

Allen H. HellerKathryn Nelson EmilyMichael Rogawski

neurologyclinical trialsacute treatmentopen-label proof-of-concept trialclinical neurologymigraineoral fospropofol

Gabaa Receptors, Seizures, and Epilepsy. Oxford University Press eBooks (2024)

Richard W. OlsenMartin WallnerMichael A. Rogawski

neurologygabaa receptorsepilepsy

Interim Long-Term Safety and Efficacy of Xen1101, a Potent, Selective Potassium Channel Opener: Update From an Ongoing Open-Label Extension of a Phase 2B Study (X-Tole) in Adults With Focal Epilepsy (S19.005). Neurology (2024)

Jacqueline FrenchRoger PorterEmilio PeruccaMartin BrodieMichael RogawskiCynthia HardenJenny QianConstanza Luzon RosenblutChristopher KenneyGregory Beatch

pharmacologyneurologyepilepsyfocal epilepsyinterim long-term safety

Efficacy and Safety of Xen1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy. JAMA Neurology (2023)

Jacqueline A. FrenchRoger J. PorterEmilio PeruccaMartin J. BrodieMichael A. RogawskiSimon PimstoneErnesto AycardiCynthia HardenJenny QianConstanza Luzon RosenblutChristopher KenneyGregory N. BeatchRobert ArmstrongEkrem KutluayPavel KleinToufic FakhouryKore LiowStephen FlitmanVictor BitonMichael SperlingDavid KudrowMercedes JacobsonKamil DetynieckiFawad Ahmed Khan (Prev: Ramsay)Evan FertigAhmad Saeed AtaDean NaritokuBassel Abou-KhalilSasha AlickSami AboumatarStephanie Callow (Prev: Moseley)Shahram Izadyar (Prev: Beach)Robert WechslerJerzy SzaflarskiNathan FountainImran AliGeorge LiTheresa Rodgers-NeameElizabeth WaterhouseSelim BenbadisSteve ChungMaria SamJoanne RoginEric SegalClaude SteriadeAmir ArainRichard PellegrinoKenneth LaxerMushtaque ChacharConrad NieveraMax BenzaquenDavid GlossAhmed SadekLixin ZhangWei MaAashit ShahJames ValerianoHeidi HenningerJeffrey Tsai (Prev: Miller)Brian MoseleyRuben KuznieckyJerry ShihGregory CascinoAlberto Pinzon-ArdilaElizabeth GerardSamiya RashidUtku UysalSamuel DestefanoWilliam TatumSuparna Krishnaiengar (Prev: Bautista)Raymond FaughtEric GellerRolando AniaBaljeet SethiBarbara PhillipsMicaela ChatmanEric Segal(Satellite)Andrew LermanNaoir ZaherRicardo AyalaMichael GelfandDavid LeschDavid VosslerPaul LyonsRuben Kuzniecky (Satellite)David SteinerMartin del CampoJean-François ClementSeyed MirsattariMary ConnollyCraig HeathMark RichardsonKhalid HamandiElizabeth GaliziaKathleen WhiteAnthony MarsonRhys ThomasBernhard SteinhoffChristian BrandtHolger Lerche

neurologyfocal epilepsyepilepsy

Tolerability and Pharmacokinetics of Intravenous Allopregnanolone With and Without Midazolam Pretreatment in Two Healthy Dogs. Epilepsia Open (2023)

Donald A. BruunBetty MaYi‐Je ChenChun‐Yi WuMonica AlemanDorota ZolkowskaSuzette M. Smiley‐JewellMichael A. RogawskiPamela J. Lein

pharmacologyhealthy dogsintravenous allopregnanolonepharmacokineticsmidazolam pretreatmentepilepsy

Xen1101, a Novel Potassium Channel Modulator: Interim Data From an Ongoing, Long-Term, Open-Label Extension of a Phase 2B Study (X-Tole) in Adults With Focal Epilepsy (S44.008). Neurology (2023)

Jacqueline FrenchRoger PorterEmilio PeruccaMartin BrodieMichael RogawskiCynthia HardenJenny QianConstanza Luzon-RosenblutChristopher KenneyGregory Beatch

pharmacologyneurologyinterim dataneurosciencefocal epilepsyopen-label extensionneuropharmacology

A Randomized, Open‐Label, Two‐Treatment Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of Diazepam Nasal Spray in Healthy Adults. Epilepsia (2022)

Michael A. RogawskiGary Slatko

neurologypharmacologytreatment effectsrespiratory medicinemedicinehealthy adultsdiazepam nasal spraytwo-treatment crossover studypharmacokineticsepilepsycohort studies

Phase 2B Efficacy and Safety of Xen1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy (X-Tole) (P12-8.006). Neurology (2022)

Jacqueline FrenchRoger PorterEmilio PeruccaMartin BrodieMichael RogawskiSimon PimstoneErnesto AycardiCynthia HardenYi XuConstanza LuzonChristopher KenneyGregory Beatch

pharmacologyneurologyfocal epilepsyepilepsy

Cortical Excitability Threshold Can Be Increased by the Ampa Blocker Perampanel in Amyotrophic Lateral Sclerosis. Muscle & Nerve (2021)

Björn OskarssonElizabeth A. MauricioJaimin S. ShahZhuo LiMichael A. Rogawski

neurologyamyotrophic lateral sclerosiscortical excitability thresholdneuroscienceampa blocker perampanelneurophysiologyelectrophysiology

1
2
3
4
5
30
10 / page

Michael A. Rogawski

University of California, Davis

Affiliations

School of Medicine

Neurology

NoneMichael A. Rogawski is currently serving as a Neurology faculty at University of California, Davis.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Michael A. Rogawski

University of California, Davis

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Crossover Study Evaluating the Effect of Seizures on the Absorption of Diazepam From a Buccal Film Formulation in Children With Epilepsy (P9-1.006). Neurology (2024)

Gary SlatkoStephen WargackiMichael Rogawski

buccal film formulationpharmacologyneurologychild neurologyabsorptioncrossover studyepilepsy

Efficacy of Ep102 (Oral Fospropofol) for the Acute Treatment of Migraine in an Open-Label Proof-Of-Concept Trial: Effect of Time to Treatment (P6-12.009). Neurology (2024)

Allen H. HellerKathryn Nelson EmilyMichael Rogawski

neurologyclinical trialsacute treatmentopen-label proof-of-concept trialclinical neurologymigraineoral fospropofol

Gabaa Receptors, Seizures, and Epilepsy. Oxford University Press eBooks (2024)

Richard W. OlsenMartin WallnerMichael A. Rogawski

neurologygabaa receptorsepilepsy

Jacqueline FrenchRoger PorterEmilio PeruccaMartin BrodieMichael RogawskiCynthia HardenJenny QianConstanza Luzon RosenblutChristopher KenneyGregory Beatch

pharmacologyneurologyepilepsyfocal epilepsyinterim long-term safety

Efficacy and Safety of Xen1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy. JAMA Neurology (2023)

neurologyfocal epilepsyepilepsy

Tolerability and Pharmacokinetics of Intravenous Allopregnanolone With and Without Midazolam Pretreatment in Two Healthy Dogs. Epilepsia Open (2023)

Donald A. BruunBetty MaYi‐Je ChenChun‐Yi WuMonica AlemanDorota ZolkowskaSuzette M. Smiley‐JewellMichael A. RogawskiPamela J. Lein

pharmacologyhealthy dogsintravenous allopregnanolonepharmacokineticsmidazolam pretreatmentepilepsy

Xen1101, a Novel Potassium Channel Modulator: Interim Data From an Ongoing, Long-Term, Open-Label Extension of a Phase 2B Study (X-Tole) in Adults With Focal Epilepsy (S44.008). Neurology (2023)

Jacqueline FrenchRoger PorterEmilio PeruccaMartin BrodieMichael RogawskiCynthia HardenJenny QianConstanza Luzon-RosenblutChristopher KenneyGregory Beatch

pharmacologyneurologyinterim dataneurosciencefocal epilepsyopen-label extensionneuropharmacology

A Randomized, Open‐Label, Two‐Treatment Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of Diazepam Nasal Spray in Healthy Adults. Epilepsia (2022)

Michael A. RogawskiGary Slatko

neurologypharmacologytreatment effectsrespiratory medicinemedicinehealthy adultsdiazepam nasal spraytwo-treatment crossover studypharmacokineticsepilepsycohort studies

Phase 2B Efficacy and Safety of Xen1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy (X-Tole) (P12-8.006). Neurology (2022)

Jacqueline FrenchRoger PorterEmilio PeruccaMartin BrodieMichael RogawskiSimon PimstoneErnesto AycardiCynthia HardenYi XuConstanza LuzonChristopher KenneyGregory Beatch

pharmacologyneurologyfocal epilepsyepilepsy

Cortical Excitability Threshold Can Be Increased by the Ampa Blocker Perampanel in Amyotrophic Lateral Sclerosis. Muscle & Nerve (2021)

Björn OskarssonElizabeth A. MauricioJaimin S. ShahZhuo LiMichael A. Rogawski

neurologyamyotrophic lateral sclerosiscortical excitability thresholdneuroscienceampa blocker perampanelneurophysiologyelectrophysiology

1
2
3
4
5
30
10 / page

Similar Faculty Members

Richard Olsen

Institution

University of California, Los Angeles

neuropsychopharmacology

gaba-a receptor proteins

Theodore Slotkin

Institution

Duke University

neuroscience

pharmacology

Robert Messing

Institution

University of Texas at Austin

neuroscience

neurology

James W. Simpkins

Institution

West Virginia University

beta amyloid

cerebral blood flow

Heike Wulff

Institution

University of California, Davis

pharmacological research

neuropsychopharmacology

A. Leslie Morrow

Institution

University of North Carolina at Chapel Hill

endogenous neurosteroids

depression

Paul Worley

Institution

Johns Hopkins University

neuroscience

neurology

Juan M. Saavedra

Institution

Georgetown University

free radical biology

neuroprotection

Daniele Piomelli

Institution

University of California, Irvine

pharmacological research

neuropsychopharmacology

Ru-Rong Ji

Institution

Duke University

neuroscience

neurology

Similar Faculty Members

Richard Olsen

Institution

University of California, Los Angeles

neuropsychopharmacology

gaba-a receptor proteins

Theodore Slotkin

Institution

Duke University

neuroscience

pharmacology

Robert Messing

Institution

University of Texas at Austin

neuroscience

neurology

James W. Simpkins

Institution

West Virginia University

beta amyloid

cerebral blood flow

Heike Wulff

Institution

University of California, Davis

pharmacological research

neuropsychopharmacology

A. Leslie Morrow

Institution

University of North Carolina at Chapel Hill

endogenous neurosteroids

depression

Paul Worley

Institution

Johns Hopkins University

neuroscience

neurology

Juan M. Saavedra

Institution

Georgetown University

free radical biology

neuroprotection

Daniele Piomelli

Institution

University of California, Irvine

pharmacological research

neuropsychopharmacology

Ru-Rong Ji

Institution

Duke University

neuroscience

neurology